MedTrace Logo

Effect of Traditional Chinese Medicine of Severe COVID-19

NCT06714032 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 172

Last updated 2024-12-03

No results posted yet for this study

Summary

This study evaluated the effect of integrated traditional Chinese and Western medicine in the treatment of Severe COVID-19. The patients were randomly divided into experimental group and control group.

Conditions

  • Severe COVID-19

Interventions

DRUG

TCM plus conventional drug

All patients were treated according to international guidelines. The Experimental group will receive TCM according to the TCM syndrome.

DRUG

TCM placebo plus conventional drug

All patients were treated according to international guidelines. The control group will receive TCM placebo according to the TCM syndrome.

Sponsors & Collaborators

  • Henan University of Traditional Chinese Medicine

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-29
Primary Completion
2023-11-08
Completion
2024-01-25

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06714032 on ClinicalTrials.gov